Studies suggest that transcription mediator factor 1-gamma (TIF1-γ), released by cancer cells, triggers the production of TIF1-γ antibodies, which in turn can lead to the development of dermatomyositis [118]. The gene discussed is TRIM33; the disease is dermatomyositis.